INVESTIGADORES
AGÜERO Fernan Gonzalo
congresos y reuniones científicas
Título:
ANTIGENIC AND FUNCTIONAL STUDIES ON TRYPOMASTIGOTE SMALL SURFACE ANTIGEN OF Trypanosoma cruzi
Autor/es:
BALOUZ V; CAMARA MM; CANEPA GE; CARMONA SJ; VOLCOVICH R; ALTCHEH J; AGÜERO F; A BUSCAGLIA, CARLOS
Lugar:
Mar del Plata
Reunión:
Congreso; X Congreso de Protozoología y Enfermedades Parasitarias; 2014
Institución organizadora:
Sociedad Argentina de Protozoología y Enfermedades Parasitaria
Resumen:
The Trypomastigote Small Surface Antigen (TSSA) is a mucin-like molecule
27 from Trypanosoma cruzi, the etiological agent of Chagas Disease, showing amino
28 acid polymorphisms among parasite isolates. TSSA expression is restricted to the
29 surface of infective cell-derived trypomastigotes, where it functions as an adhesin,
30 engaging surface receptor(s) on the host cell as a prerequisite for parasite
31 internalization. Previous results have established TSSA-CL, the isoform encoded
32 by the CL Brener clone, as an appealing candidate for serology-based diagnostics
33 in Chagas Disease. Here, we used a combination of peptide- and recombinant
34 protein-based tools to map at maximal resolution the antigenic structure of TSSA-
35 CL. Our results indicate the presence of different, partially overlapping B-cell
36 epitope(s) clustering in the central portion of TSSA-CL, which contains most of the
37 polymorphisms across parasite isolates. Based on these results, we assessed the
38 serodiagnostic performance of a 21-amino acid long peptide spanning TSSA-CL
39 major antigenic determinants, which was similar to the performance of the
40 previously validated GST-TSSA-CL fusion molecule. Furthermore, the tools
41 developed for the antigenic characterization of the TSSA antigen were also used to
42 explore other potential diagnostic applications of the anti-TSSA humoral response
43 in Chagasic patients. Overall, our present results provide additional insights on
44 TSSA-CL antigenic structure, and support this molecule as an excellent target for
45 molecular intervention in Chagas Disease.